Could a finger prick replace the needle for inflammation tests?

NCT ID NCT07435285

Recruiting now Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a simple finger-prick blood spot can measure inflammatory markers as accurately as a standard blood draw from a vein. Researchers will collect both types of samples from 50 adults before and after a planned stressor, like a vaccine, which temporarily raises inflammation. If successful, this could offer a less painful and more convenient way to monitor inflammation in research and healthcare.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If DBS works as well as standard blood draws, it could make inflammation testing easier and less invasive for patients.
What could go wrong: This is a small, early study (50 people) comparing two sampling methods, not testing a treatment. The results may not apply to all settings or conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD SAMPLING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD SAMPLING DRIED BLOOD SPOT INFLAMMATION INFLAMMATION BIOMARKERS

Contacts and locations

Locations

Research Institute of the McGill University Health Centre
RECRUITING

Montreal, Quebec, H4A 0B1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.